Studying the evolution of acute myeloid leukemia (AML) relapse
Refining and improving treatment options in CLL
Treatment for older AML patients - when is an allogeneic transplant suitable?
What we are learning about CLL treatments and the microenvironment
ASH 2015 highlights in multiple myeloma by Prof. Ola Landgren